Condensed Consolidated Statements of Stockholders’ (Deficit) Equity (Unaudited) - USD ($) $ in Thousands	FOXO Technologies Operating Company Series A Preferred Stock Note Warrant	FOXO Technologies Operating Company Series A Preferred Stock Employee Stock	FOXO Technologies Operating Company Series A Preferred Stock Private Placement	FOXO Technologies Operating Company Series A Preferred Stock	FOXO Technologies Operating Company Class A Common Stock Note Warrant	FOXO Technologies Operating Company Class A Common Stock Employee Stock	FOXO Technologies Operating Company Class A Common Stock Private Placement	FOXO Technologies Operating Company Class A Common Stock	FOXO Technologies Operating Company Class B Common Stock Note Warrant	FOXO Technologies Operating Company Class B Common Stock Employee Stock	FOXO Technologies Operating Company Class B Common Stock Private Placement	FOXO Technologies Operating Company Class B Common Stock	FOXO Technologies Inc. Class A Common Stock Note Warrant	FOXO Technologies Inc. Class A Common Stock Employee Stock	FOXO Technologies Inc. Class A Common Stock Private Placement	FOXO Technologies Inc. Class A Common Stock	FOXO Technologies Inc. Treasury Stock Employee Stock	FOXO Technologies Inc. Treasury Stock Private Placement	FOXO Technologies Inc. Treasury Stock	Additional Paid-in Capital Note Warrant	Additional Paid-in Capital Employee Stock	Additional Paid-in Capital Private Placement	Additional Paid-in Capital	Accumulated Deficit Note Warrant	Accumulated Deficit Employee Stock	Accumulated Deficit Private Placement	Accumulated Deficit	Note Warrant	Employee Stock	Private Placement	Total
Balance beginning at Dec. 31, 2021				$ 21,854																			$ 4,902				$ (51,976)				$ (25,220)
Balance beginning (in Shares) at Dec. 31, 2021				800,000				3,021				200,000
Net loss to common stockholders																								$ (31,495)	$ (45,437)			$ 31,495	$ (45,437)		(76,932)
Lease contributions																							225								225
Equity-based compensation																$ 1							329								330
Equity-based compensation (in Shares)																917,500
Cantor Commitment Fee																							1,600								1,600
Cantor Commitment Fee (in Shares)																19,048
Balance ending at Sep. 30, 2022																$ 3							144,672				(128,908)				15,767
Balance ending (in Shares) at Sep. 30, 2022																3,302,784
Equity-based compensation																							717								717
Warrant repurchase																							(507)								(507)
Issuance of shares for exercised stock options
Issuance of shares for exercised stock options (in Shares)								1,495
Issuance of shares for consulting agreement																							211								211
Issuance of shares for consulting agreement (in Shares)								150,000
Conversion of Series A Preferred Stock				$ (21,854)																			21,854
Conversion of Series A Preferred Stock (in Shares)				(800,000)				800,000
Conversion of Bridge Loans																							88,975								88,975
Conversion of Bridge Loans (in Shares)								1,517,273
Conversion of Class B Common Stock
Conversion of Class B Common Stock (in Shares)								200,000				(200,000)
Conversion of existing Class A Common Stock																$ 1															1
Conversion of existing Class A Common Stock (in Shares)								(2,671,789)								1,551,871
Reverse recapitalization																$ 1							19,677								19,678
Reverse recapitalization (in Shares)																814,365
Balance beginning at Jun. 30, 2022				$ 21,854																			12,026				(87,882)				(54,002)
Balance beginning (in Shares) at Jun. 30, 2022				800,000				154,516				200,000
Net loss to common stockholders																								$ (9,531)	$ (31,495)			$ (9,531)	$ (31,495)		(41,026)
Net loss to common stockholders (in Shares)
Equity-based compensation																$ 1							329								330
Equity-based compensation (in Shares)																917,500
Cantor Commitment Fee																							1,600								1,600
Cantor Commitment Fee (in Shares)																19,048
Balance ending at Sep. 30, 2022																$ 3							144,672				(128,908)				15,767
Balance ending (in Shares) at Sep. 30, 2022																3,302,784
Equity-based compensation																							211								211
Conversion of Series A Preferred Stock				$ (21,854)																			21,854
Conversion of Series A Preferred Stock (in Shares)				(800,000)				800,000
Conversion of Bridge Loans																							88,975								88,975
Conversion of Bridge Loans (in Shares)								1,517,273
Conversion of Class B Common Stock
Conversion of Class B Common Stock (in Shares)								200,000				(200,000)
Conversion of existing Class A Common Stock																$ 1															1
Conversion of existing Class A Common Stock (in Shares)								(2,671,789)								1,551,871
Reverse recapitalization																$ 1							19,677								19,678
Reverse recapitalization (in Shares)																814,365
Balance beginning at Dec. 31, 2022																$ 3							153,936				(147,231)				6,708
Balance beginning (in Shares) at Dec. 31, 2022																2,966,967			(214,077)
Net loss to common stockholders																											(25,058)				(25,058)
Stock-based compensation																							226								226
Stock-based compensation (in Shares)																(365,132)
2022 Debenture Release																$ 1							2,180								2,181
2022 Debenture Release (in Shares)																703,500
PIK Note Amendment																							1,339								1,339
PIK Note Amendment (in Shares)																432,188
Exchange Offer																$ 1							2,466								2,467
Exchange Offer (in Shares)																795,618
Private placements net of issuance costs																$ 1							443								443
Private placements net of issuance costs (in Shares)																929,376
Issuance of shares to Joseph Gunner																							221								221
Issuance of shares to Joseph Gunner (in Shares)																276,875
Treasury stock
Treasury stock (in Shares)																(214,077)			214,077
Issuance of shares to MSK																							234								234
Issuance of shares to MSK (in Shares)																292,867
Issuance of shares to employees																							135								135
Issuance of shares to employees (in Shares)																98,670
Cantor Commitment Fee
Balance ending at Sep. 30, 2023															$ 6	$ 5						$ 161,180	161,180			$ (172,289)	(172,289)			$ (11,103)	(11,103)
Balance ending (in Shares) at Sep. 30, 2023															5,916,852	5,916,852
Balance beginning at Jun. 30, 2023																$ 5							161,594				(168,629)				(7,030)
Balance beginning (in Shares) at Jun. 30, 2023																4,648,096
Net loss to common stockholders																											(3,660)				(3,660)
Stock-based compensation																							(1,447)								(1,447)
Stock-based compensation (in Shares)																(329,032)
Private placements net of issuance costs																$ 1							443								444
Private placements net of issuance costs (in Shares)																929,376
Issuance of shares to Joseph Gunner																							221								221
Issuance of shares to Joseph Gunner (in Shares)																276,875
Issuance of shares to MSK																							234								234
Issuance of shares to MSK (in Shares)																292,867
Issuance of shares to employees																							135								135
Issuance of shares to employees (in Shares)																98,670
Balance ending at Sep. 30, 2023															$ 6	$ 5						$ 161,180	$ 161,180			$ (172,289)	$ (172,289)			$ (11,103)	$ (11,103)
Balance ending (in Shares) at Sep. 30, 2023															5,916,852	5,916,852